Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

A prospective phase I/II clinical trial led by QST Hospital reports that carbon-ion radiotherapy achieved five-year local control and disease-free survival rates of 92%, with no grade ≥2 toxicities, ...

An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers.

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An ...

According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...

The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied in the early ...

Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

Study Results Support the use of TellDx to Personalize Cancer Care Management –-- Clinical study published in Cancer Discovery --ANDOVER, ...

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...